U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230171) titled 'The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia' on Nov. 13.
Brief Summary: Fibromyalgia is a chronic pain syndrome where current medications have limited efficacy and a slow onset of action. Esketamine shows potential as a rapid-acting analgesic, but previous low-dose studies failed to demonstrate long-term benefits. The efficacy of higher-dose ESK as an adjunctive therapy when standard treatments are insufficient remains unclear.
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Fibromyalgia
Pregabalin
Esketamine
Intervention:
DRUG: Pregabalin an...